| Insight into nanoparticle cellular uptake and intracellular targeting B Yameen, WI Choi, C Vilos, A Swami, J Shi, OC Farokhzad Journal of controlled release 190, 485-499, 2014 | 802 | 2014 |
| Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticle for small interfering RNA delivery J Shi, Z Xiao, AR Votruba, C Vilos, OC Farokhzad Angewandte Chemie (International ed. in English) 50 (31), 7027, 2011 | 202 | 2011 |
| Targeted interleukin-10 nanotherapeutics developed with a microfluidic chip enhance resolution of inflammation in advanced atherosclerosis N Kamaly, G Fredman, JJR Fojas, M Subramanian, WII Choi, K Zepeda, ... ACS nano 10 (5), 5280-5292, 2016 | 201 | 2016 |
| Role of oxidative stress as key regulator of muscle wasting during cachexia J Ábrigo, AA Elorza, CA Riedel, C Vilos, F Simon, D Cabrera, L Estrada, ... Oxidative medicine and cellular longevity 2018 (1), 2063179, 2018 | 184 | 2018 |
| Targeted nanoparticles for colorectal cancer BA Cisterna, N Kamaly, WI Choi, A Tavakkoli, OC Farokhzad, C Vilos Nanomedicine 11 (18), 2443-2456, 2016 | 143 | 2016 |
| Lipid-polymer hybrid particles J Shi, Z Xiao, C Vilos, A Votruba, RS Langer, OC Farokhzad US Patent 9,549,901, 2017 | 128 | 2017 |
| Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells C Vilos, FA Morales, PA Solar, NS Herrera, FD Gonzalez-Nilo, DA Aguayo, ... Biomaterials 34 (16), 4098-4108, 2013 | 113 | 2013 |
| Therapeutic strategies based on polymeric microparticles C Vilos, LA Velasquez BioMed Research International 2012 (1), 672760, 2012 | 104 | 2012 |
| Active acetylcholine receptors prevent the atrophy of skeletal muscles and favor reinnervation BA Cisterna, AA Vargas, C Puebla, P Fernández, R Escamilla, CF Lagos, ... Nature communications 11 (1), 1073, 2020 | 80 | 2020 |
| Intracellular trafficking and cellular uptake mechanism of PHBV nanoparticles for targeted delivery in epithelial cell lines JP Peñaloza, V Márquez-Miranda, M Cabaña-Brunod, R Reyes-Ramírez, ... Journal of nanobiotechnology 15, 1-15, 2017 | 76 | 2017 |
| Mitochondrial dysfunction in skeletal muscle pathologies J Abrigo, F Simon, D Cabrera, C Vilos, C Cabello-Verrugio Current Protein and Peptide Science 20 (6), 536-546, 2019 | 75 | 2019 |
| Bioinformatic detection of E47, E2F1 and SREBP1 transcription factors as potential regulators of genes associated to acquisition of endometrial receptivity A Tapia, C Vilos, JC Marín, HB Croxatto, L Devoto Reproductive Biology and Endocrinology 9, 1-14, 2011 | 69 | 2011 |
| TGF-β requires the activation of canonical and non-canonical signalling pathways to induce skeletal muscle atrophy J Ábrigo, F Campos, F Simon, C Riedel, D Cabrera, C Vilos, ... Biological chemistry 399 (3), 253-264, 2018 | 46 | 2018 |
| Nanotechnology and primary hemostasis: Differential effects of nanoparticles on platelet responses MF Matus, C Vilos, BA Cisterna, E Fuentes, I Palomo Vascular pharmacology, 2018 | 41 | 2018 |
| A Solvent-Free Thermosponge Nanoparticle Platform for Efficient Delivery of Labile Proteins FOC Choi WI, Kamaly N, Riol-Blanco L, Lee IH, Wu J, Swami A, Vilos C, Yameen ... Nano Lett., 2014 | 41 | 2014 |
| Targeted brain delivery nanoparticles for malignant gliomas MP Pinto, M Arce, B Yameen, C Vilos Nanomedicine 12 (1), 59-72, 2017 | 39 | 2017 |
| Multifunctional polymeric nanoparticles doubly loaded with SPION and ceftiofur retain their physical and biological properties P Solar, G González, C Vilos, N Herrera, N Juica, M Moreno, F Simon, ... Journal of nanobiotechnology 13, 1-12, 2015 | 37 | 2015 |
| Ceftiofur-loaded PHBV microparticles: A potential formulation for a long-acting antibiotic to treat animal infections C Vilos, L Constandil, N Herrera, P Solar, J Escobar-Fica, LA Velásquez Electronic Journal of Biotechnology 15 (4), 1-1, 2012 | 35 | 2012 |
| The critical role of oxidative stress in sarcopenic obesity A Gonzalez, F Simon, O Achiardi, C Vilos, D Cabrera, C Cabello-Verrugio Oxidative Medicine and Cellular Longevity 2021 (1), 4493817, 2021 | 32 | 2021 |
| Potassium channels as a target for cancer therapy: Current perspectives L Zúñiga, A Cayo, W González, C Vilos, R Zúñiga OncoTargets and therapy 15, 783, 2022 | 28 | 2022 |
